title: Novel targeted treatment strategies for refractory chronic lymphocytic leukaemia.
abstract: Patients with refractory chronic lymphocytic leukaemia (CLL) still have an unfavourable prognosis and novel treatment strategies are necessary, preferably adjusted to the patient's individual situation. Refractoriness is no longer limited just to fludarabine (F) but extends to F-combinations with other chemotherapeutic agents (e.g. cyclophosphamide [C] and FC) and antibodies (e.g. rituximab [R], FR, and FCR). Also, refractoriness to alemtuzumab is an increasing problem. New pharmacological developments provide promising approaches. This review focuses on novel therapies such as monoclonal antibodies and small molecules aiming at specific targets of the CLL cell in the refractory situation. Approved therapeutic regimens will be presented as well as investigational approaches. An overview of completed and current clinical trials is offered.
authors.affiliation: Klinik für Innere Medizin III, Hämatologie, Onkologie, Rheumatologie und Infektionskrankheiten, Universitatsklinikum Ulm, Albert-Einstein-Allee 23, D-89081 Ulm, Germany.
authors.forename: Andrea
authors.initials: A
authors.lastname: Schnaiter
authors.forename: Stephan
authors.initials: S
authors.lastname: Stilgenbauer
keywords: CLL; monoclonal antibodies; refractory; small molecules
references.citation: Cell Mol Life Sci. 2002 Oct;59(10):1640-8
references.pmid: 12475174
references.citation: Leukemia. 2008 Nov;22(11):2048-53
references.pmid: 18754025
references.citation: Leuk Lymphoma. 2010 Jan;51(1):27-38
references.pmid: 20055657
references.citation: Cancer Chemother Pharmacol. 2009 Sep;64(4):723-32
references.pmid: 19169685
references.citation: J Immunol. 2006 Jul 1;177(1):362-71
references.pmid: 16785532
references.citation: Blood. 2005 Oct 1;106(7):2506-12
references.pmid: 15972449
references.citation: J Clin Oncol. 2006 Dec 1;24(34):5343-9
references.pmid: 17088571
references.citation: Cancer. 2003 Apr 1;97(7):1711-20
references.pmid: 12655528
references.citation: Blood. 2008 Feb 1;111(3):1094-100
references.pmid: 18003886
references.citation: Clin Cancer Res. 2003 May;9(5):1931-9
references.pmid: 12738752
references.citation: Semin Hematol. 2010 Apr;47(2):156-69
references.pmid: 20350663
references.citation: Blood. 2005 Oct 1;106(7):2513-9
references.pmid: 15972445
references.citation: J Clin Oncol. 2006 Apr 1;24(10):1575-81
references.pmid: 16520464
references.citation: Blood. 2008 Sep 1;112(5):1971-80
references.pmid: 18566329
references.citation: Bioorg Med Chem Lett. 2011 Feb 1;21(3):1019-22
references.pmid: 21215621
references.citation: Lancet. 2010 Oct 2;376(9747):1164-74
references.pmid: 20888994
references.citation: J Clin Oncol. 2010 Apr 1;28(10):1749-55
references.pmid: 20194866
references.citation: Blood. 2010 Jul 8;116(1):45-53
references.pmid: 20351313
references.citation: Oncogene. 2008 Apr 10;27(17):2445-55
references.pmid: 17982489
references.citation: J Clin Oncol. 2005 May 20;23(15):3404-11
references.pmid: 15824414
references.citation: Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4448-55
references.pmid: 17671129
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19512-7
references.pmid: 18040043
references.citation: Blood. 2010 Jan 21;115(3):489-95
references.pmid: 19843887
references.citation: J Clin Oncol. 2008 Jan 10;26(2):196-203
references.pmid: 18182662
references.citation: Clin Cancer Res. 2010 Aug 15;16(16):4217-25
references.pmid: 20601444
references.citation: Leukemia. 1991 Jun;5(6):522-7
references.pmid: 1711641
references.citation: Blood. 2010 Jun 3;115(22):4393-402
references.pmid: 20194898
references.citation: Cancer Res. 1997 Apr 15;57(8):1487-94
references.pmid: 9108450
references.citation: Blood. 2008 Jun 1;111(11):5291-7
references.pmid: 18334676
references.citation: Blood. 2002 May 15;99(10):3554-61
references.pmid: 11986207
references.citation: Blood. 2000 Jul 15;96(2):393-7
references.pmid: 10887097
references.citation: Blood. 1995 Mar 15;85(6):1580-9
references.pmid: 7888675
references.citation: Blood. 2008 Jun 15;111(12):5446-56
references.pmid: 18216293
references.citation: Br J Haematol. 2007 Dec;139(5):837-44
references.pmid: 17949452
references.citation: Haematologica. 2008 Mar;93(3):475-6
references.pmid: 18310545
references.citation: J Clin Oncol. 2009 Dec 10;27(35):6012-8
references.pmid: 19826119
references.citation: Cancer Res. 2004 Aug 1;64(15):5471-80
references.pmid: 15289357
references.citation: J Clin Oncol. 2005 Oct 20;23(30):7697-702
references.pmid: 16186597
references.citation: Leuk Res. 2005 Nov;29(11):1253-7
references.pmid: 15916806
references.citation: J Clin Oncol. 2010 Jun 20;28(18):3015-22
references.pmid: 20479412
references.citation: Blood. 2003 Sep 1;102(5):1641-8
references.pmid: 12738665
references.citation: Blood. 2004 Mar 1;103(5):1855-61
references.pmid: 14576064
references.citation: J Immunol. 1999 Jul 1;163(1):380-6
references.pmid: 10384139
references.citation: Science. 2010 Nov 5;330(6005):827-30
references.pmid: 21051638
references.citation: Blood. 2009 May 7;113(19):4637-45
references.pmid: 19234140
references.citation: Blood. 1998 Nov 15;92(10):3804-16
references.pmid: 9808574
references.citation: J Clin Oncol. 2005 Jun 20;23(18):4070-8
references.pmid: 15767647
references.citation: J Clin Oncol. 2009 Aug 20;27(24):3994-4001
references.pmid: 19597025
references.citation: Blood. 2008 Feb 1;111(3):1594-602
references.pmid: 18032710
references.citation: Clin Cancer Res. 2011 Apr 1;17(7):1935-46
references.pmid: 21307145
references.citation: Blood. 2004 Sep 15;104(6):1793-800
references.pmid: 15172969
references.citation: J Clin Oncol. 2010 Oct 10;28(29):4473-9
references.pmid: 20697090
references.citation: Blood. 2009 Jan 8;113(2):299-305
references.pmid: 18931344
references.citation: Blood. 1989 Jul;74(1):19-25
references.pmid: 2473795
references.citation: Blood. 2010 Sep 23;116(12):2078-88
references.pmid: 20522708
references.citation: J Clin Oncol. 2009 Nov 1;27(31):5208-12
references.pmid: 19738118
references.citation: Blood. 2009 Jan 1;113(1):149-53
references.pmid: 18836097
references.citation: Blood. 2008 Aug 15;112(4):975-80
references.pmid: 18411418
references.citation: Nat Rev Mol Cell Biol. 2010 Jul;11(7):515-28
references.pmid: 20531426
references.citation: Cell Death Differ. 2008 May;15(5):820-30
references.pmid: 18309326
references.citation: Blood. 2009 Mar 19;113(12):2637-45
references.pmid: 18981292
references.citation: Br J Haematol. 2005 Feb;128(4):472-81
references.pmid: 15686454